1
|
Abayomi A, Osibogun A, Kanma-Okafor O, Idris J, Bowale A, Wright O, Adebayo B, Balogun M, Ogboye S, Adeseun R, Abdus-Salam I, Mutiu B, Saka B, Lajide D, Yenyi S, Agbolagorite R, Onasanya O, Erinosho E, Obasanya J, Adejumo O, Adesola S, Oshodi Y, Akase IE, Ogunbiyi S, Omosun A, Erinoso F, Abdur-Razzaq H, Osa N, Akinroye K. Correction to: Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study. Glob Health Res Policy 2021; 6:28. [PMID: 34389063 PMCID: PMC8360807 DOI: 10.1186/s41256-021-00215-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Affiliation(s)
- Akin Abayomi
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Akin Osibogun
- College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria. .,Lagos State Primary Health Care Board, Lagos, Nigeria.
| | | | - Jide Idris
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | | | - Ololade Wright
- Lagos State University College of Medicine, Lagos, Nigeria
| | - Bisola Adebayo
- Lagos State University College of Medicine, Lagos, Nigeria
| | | | - Segun Ogboye
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Remi Adeseun
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Ismael Abdus-Salam
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | | | | | - Dayo Lajide
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Sam Yenyi
- World Health Organization, Nigeria Office, Abuja, Nigeria
| | - Rotimi Agbolagorite
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | | | | | | | | | | | - Yewande Oshodi
- College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria
| | | | | | - Adenike Omosun
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Femi Erinoso
- Lagos State University Teaching Hospital, Lagos, Nigeria
| | - Hussein Abdur-Razzaq
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Nike Osa
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | | |
Collapse
|
2
|
Abayomi A, Osibogun A, Kanma-Okafor O, Idris J, Bowale A, Wright O, Adebayo B, Balogun M, Ogboye S, Adeseun R, Abdus-Salam I, Mutiu B, Saka B, Lajide D, Yenyi S, Agbolagorite R, Onasanya O, Erinosho E, Obasanya J, Adejumo O, Adesola S, Oshodi Y, Akase IE, Ogunbiyi S, Omosun A, Erinoso F, Abdur-Razzaq H, Osa N, Akinroye K. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study. Glob Health Res Policy 2021; 6:26. [PMID: 34325747 PMCID: PMC8319704 DOI: 10.1186/s41256-021-00210-6] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2020] [Accepted: 06/20/2021] [Indexed: 12/24/2022] Open
Abstract
BACKGROUND The current pandemic of coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown epidemiological and clinical characteristics that appear worsened in hypertensive patients. The morbidity and mortality of the disease among hypertensive patients in Africa have yet to be well described. METHODS In this retrospective cohort study all confirmed COVID-19 adult patients (≥18 years of age) in Lagos between February 27 to July 62,020 were included. Demographic, clinical and outcome data were extracted from electronic medical records of patients admitted at the COVID-19 isolation centers in Lagos. Outcomes included dying, being discharged after recovery or being evacuated/transferred. Descriptive statistics considered proportions, means and medians. The Chi-square and Fisher's exact tests were used in determining associations between variables. Kaplan-Meier survival analysis and Cox regression were performed to quantify the risk of worse outcomes among hypertensives with COVID-19 and adjust for confounders. P-value ≤0.05 was considered statistically significant. RESULTS A total of 2075 adults with COVID-19 were included in this study. The prevalence of hypertension, the most common comorbidity, was 17.8% followed by diabetes (7.2%) and asthma (2.0%). Overall mortality was 4.2% while mortality among the hypertensives was 13.7%. Severe symptoms and mortality were significantly higher among the hypertensives and survival rates were significantly lowered by the presence of additional comorbidity to 50% from 91% for those with hypertension alone and from 98% for all other patients (P < 0.001). After adjustment for confounders (age and sex), severe COVID-19and death were higher for hypertensives {severe/critical illness: HR = 2.41, P = 0.001, 95%CI = 1.4-4.0, death: HR = 2.30, P = 0.001, 95%CI = 1.2-4.6, for those with hypertension only} {severe/critical illness: HR = 3.76, P = 0.001, 95%CI = 2.1-6.4, death: crude HR = 6.63, P = 0.001, 95%CI = 3.4-1.6, for those with additional comorbidities}. Hypertension posed an increased risk of severe morbidity (approx. 4-fold) and death (approx. 7-fold) from COVID-19 in the presence of multiple comorbidities. CONCLUSION The potential morbidity and mortality risks of hypertension especially with other comorbidities in COVID-19 could help direct efforts towards prevention and prognostication. This provides the rationale for improving preventive caution for people with hypertension and other comorbidities and prioritizing them for future antiviral interventions.
Collapse
Affiliation(s)
- Akin Abayomi
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Akin Osibogun
- College of Medicine University of Lagos, Idi-Araba, Lagos, Nigeria.
- Lagos State Primary Health Care Board, Lagos, Nigeria.
| | | | - Jide Idris
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | | | - Ololade Wright
- Lagos State University College of Medicine, Lagos, Nigeria
| | - Bisola Adebayo
- Lagos State University College of Medicine, Lagos, Nigeria
| | | | - Segun Ogboye
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Remi Adeseun
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Ismael Abdus-Salam
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | | | | | - Dayo Lajide
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Sam Yenyi
- World Health Organization, Nigeria Office, Abuja, Nigeria
| | - Rotimi Agbolagorite
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | | | | | | | | | | | - Yewande Oshodi
- College of Medicine University of Lagos, Idi-Araba, Lagos, Nigeria
| | | | | | - Adenike Omosun
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Femi Erinoso
- Lagos State University Teaching Hospital, Lagos, Nigeria
| | - Hussein Abdur-Razzaq
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | - Nike Osa
- Lagos State Ministry of Health/Lagos Incident Management Command System, Lagos, Nigeria
| | | |
Collapse
|
3
|
Abayomi A, Odukoya O, Osibogun A, Wright O, Adebayo B, Balogun M, Abdus-Salam I, Bowale A, Mutiu B, Saka B, Adejumo M, Yenyi S, Agbolagorite R, Onasanya O, Erinosho E, Obasanya J, Adejumo O, Adesola S, Oshodi Y, Akase IE, Ogunbiyi S, Lajide D, Erinoso F, Abdur-Razzaq H. Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria. Int J Infect Dis 2021; 102:226-232. [PMID: 33075534 PMCID: PMC7566672 DOI: 10.1016/j.ijid.2020.10.024] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2020] [Revised: 10/06/2020] [Accepted: 10/08/2020] [Indexed: 02/07/2023] Open
Abstract
INTRODUCTION Lagos state remains the epicentre of COVID-19 in Nigeria. We describe the symptoms and signs of the first 2,184 PCR-confirmed COVID-19 patients admitted at COVID-19 treatment centers in Lagos State. We also assessed the relationship between patients' presenting symptoms, sociodemographic and clinical characteristics and COVID-19 deaths.. METHODS Medical records of PCR-confirmed COVID-19 patients were extracted and analyzed for their symptoms, symptom severity, presence of comorbidities and outcome. RESULTS The ages of the patients ranged from 4 days to 98 years with a mean of 43.0(16.0) years. Of the patients who presented with symptoms, cough (19.3%) was the most common presenting symptom. This was followed by fever (13.7%) and difficulty in breathing, (10.9%). The most significant clinical predictor of death was the severity of symptoms and signs at presentation. Difficulty in breathing was the most significant symptom predictor of COVID-19 death (OR:19.26 95% CI 10.95-33.88). The case fatality rate was 4.3%. CONCLUSION Primary care physicians and COVID-19 frontline workers should maintain a high index of suspicion and prioritize the care of patients presenting with these symptoms. Community members should be educated on such predictors and ensure that patients with these symptoms seek care early to reduce the risk of deaths associated with COVID-19.
Collapse
Affiliation(s)
| | | | - Akin Osibogun
- College of Medicine University of Lagos; Lagos State Primary Health Care Board; Lagos University Teaching Hospital.
| | | | | | | | | | | | | | | | | | - Sam Yenyi
- World Health Organization, Nigeria Office
| | | | | | | | | | | | | | - Yewande Oshodi
- College of Medicine University of Lagos; Lagos University Teaching Hospital
| | | | | | | | | | | |
Collapse
|